This website requires Adobe Flash Player.
Please download the latest Flash Plugin.
Vitamin C is water soluble and cannot be stored by the body. Because it is absorbed and excreted rapidly in the gastrointestinal tract, taking an immediate release (IR) supplement does not maintain plasma levels throughout the day.
Our Diffucaps® sustained-release Vitamin C is clinically shown to maintain plasma levels throughout the day. The formulation is more convenient than IR formulations because Diffucaps® Vitamin C provides a continuous release of Vitamin C in smaller doses over a longer period of time, maintaining the nutrient’s levels over an extended period of 12 hours.
Aptalis Pharmaceutical Technologies uses their proprietary Diffucaps® technology to create a sustained-release formulation of this widely used dietary supplement. It can be licensed for use as a pharmaceutical or food product, depending on country.
Therapeutic Category |
Nutrition |
Indication |
Dietary supplement used to:
|
Development Status |
Commercialized; Licensing opportunities available |
Available Dosage Strength(s) |
|
Product Description |
12-hour sustained-release capsule formulation of vitamin C |
Technology |
Diffucaps® - Customized Drug Release technology |
Licensing Opportunities |
Aptalis Pharmaceutical Technologies is seeking licensing partners for global opportunities. |
This information is provided solely for the purpose of the evaluation of business opportunities by potential collaboration partners. The information is based on currently existing data and marketing authorizations in a number of jurisdictions and should not be assumed to be approved by regulatory authorities in any individual country. Consumers should consult with their individual physician for product information and should not rely upon any information provided here.
For more information on this product, please contact Aptalis Pharmaceutical Technologies.